Trial Profile
16-week Open Randomized Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression: Pharmacogenomic and Biomarker Predictors of Response
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2019
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Lamotrigine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- Acronyms FLAME
- 21 May 2019 Status changed from completed to discontinued.
- 23 May 2018 Status changed from recruiting to completed.
- 15 Apr 2016 Status changed from active, no longer recruiting to recruiting.